Marit J. van Gils

16.6k citations

123 papers · 3.8k indexed · 2 hit papers · h-index 30

Virology top 0.2%
- HIV Research and Treatment 57
Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 36
- HIV/AIDS drug development and treatment 19
- COVID-19 Clinical Research Studies 18
Immunology top 2%
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 12
Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research 35
Hepatology top 5%
Obstetrics and Gynecology
- COVID-19 Impact on Reproduction 14

Co-authors: Rogier W. Sanders Andrew B. Ward Ian A. Wilson John P. Moore Hanneke Schuitemaker Dennis R. Burton Jean‐Philippe Julien Albert Cupo
Cited by: Virology Infectious Diseases Immunology
Journals: Journal of Virology (12 papers)PLoS Pathogens (10 papers)Frontiers in Immunology (7 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Marit J. van Gils

119 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Marit J. van Gils

Since Specialization

Citations

This map shows the geographic impact of Marit J. van Gils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit J. van Gils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit J. van Gils more than expected).

Fields of papers citing papers by Marit J. van Gils

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit J. van Gils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit J. van Gils. The network helps show where Marit J. van Gils may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marit J. van Gils, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marit J. van Gils Line = papers co-authored together Marit J. van Gils links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Anellovirus constraint from 2 to 6 months postpartum followed by betatorquevirus and gammatorquevirus dominance in serum and milk Journal of Virology ·Camdra Santhy,Deisy Johana Valbuena Martínez,Martin Deijs,Jacqueline van Rijswijk,Marit J. van Gils,Johannes B. van Goudoever,Britt J. van Keulen,Lia van der Hoek	2025	0
2	Innovative Single-Cell Sequencing Techniques for B cell Analysis and Their Implications for Rational HIV-1 Vaccine Design Current HIV Research ·Denise Guerra,Muhammad Nahyan Dar,Tim Beaumont,Mathieu Claireaux,Marit J. van Gils	2025	0
3	Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions Antiviral Research ·昇多賀,David Falck,Manfred Wuhrer,Neeltje A. Kootstra,Marit J. van Gils,Steven W. de Taeye	2024	3
4	Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies The EMBO Journal ·Richard Burton Macfarlane,Hanmei Lou,John L. van Hamme,Doris Wilflingseder,Godelieve de Bree,Maria Prins,Menno D. de Jong,Pythia T. Nieuwkerk,Marit J. van Gils,Neeltje A. Kootstra,Teunis B. H. Geijtenbeek	2024	2
5	The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses Viruses ·Camdra Santhy,Frank M. Harron,Martin Deijs,Okamura Tadashi,A. H. Ayesha Lavell,Karlijn van der Straten,Qiucheng Han,Jacqueline van Rijswijk,Marit J. van Gils,Jonne J. Sikkens,Marije K. Bomers,Lia van der Hoek	2024	3
6	Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing Communications Biology ·Steven W. de Taeye,昇多賀,Jeffrey C. Umotoy,Marloes Grobben,Judith A. Burger,Kerry M. Brennan,Gestur Vidarsson,Manfred Wuhrer,David Falck,Neeltje A. Kootstra,Marit J. van Gils	2024	7
7	Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19 Life Science Alliance ·Chiara E. Geyer,Hung‐Jen Chen,Alexander P. Bye,Xue D. Manz,Denise Guerra,Tom G. Caniels,Tom P. L. Bijl,Guillermo R. Griffith,Willianne Hoepel,Steven W. de Taeye,N.D. Chegodaeva,Alexander P. J. Vlaar,(unknown),Gestur Vidarsson,Harm Jan Bogaard,Jurjan Aman,Jonathan M. Gibbins,Marit J. van Gils,Menno P.J. de Winther,Jeroen den Dunnen	2023	6
8	Understanding repertoire sequencing data through a multiscale computational model of the germinal center npj Systems Biology and Applications ·Zahra Faghih,Nidal El Sabayar Shevchenko,Chia-En Lee,Luka Srića,Aldo Jongejan,J Hals,健逸大木,Tom G. Caniels,Mathieu Claireaux,Anne Musters,Marit J. van Gils,María Rodríguez Martínez,Niek de Vries,Michael Meyer‐Hermann,Jeroen E. J. Guikema,Huub C. J. Hoefsloot,Antoine H. C. van Kampen	2023	3
9	Next-generation bNAbs for HIV-1 cure strategies Antiviral Research ·昇多賀,Yoann Aldon,Marit J. van Gils,Steven W. de Taeye	2023	11
10	Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination Diagnostic Microbiology and Infectious Disease ·D. W. Giesekke,金杉義衛,Jaqueline Nogueira,موسى الحسيني,Patricia Sastre,Lia van der Hoek,Marit J. van Gils,Philip J. M. Brouwer,Rogier W. Sanders,Barbara Holzer,G. Stein,Eduardo López‐Collazo,Patricia Muñóz,Paloma Rueda,Carmen Vela	2022	4
11	Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns PLoS Pathogens ·Ilhan Tomris,Kim M. Bouwman,Youri Adolfs,Danny Noack,Roosmarijn van der Woude,Gius Kerster,Sander Herfst,Rogier W. Sanders,Marit J. van Gils,Geert‐Jan Boons,Bart L. Haagmans,R. Jeroen Pasterkamp,Barry Rockx,Robert P. de Vries	2022	14
12	Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern Nature Communications ·Barry Nevin,Albert Bondt,Max Hoek,Karlijn van der Straten,Tom G. Caniels,Meliawati Poniman,Dirk Eggink,Chantal Reusken,Godelieve J. de Bree,Rogier W. Sanders,Marit J. van Gils,Albert J. R. Heck	2022	11
13	Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates PLoS Pathogens ·Jelle van Schooten,Marlies M. van Haaren,Hui Li,Laura E. McCoy,Colin Havenar‐Daughton,Christopher A. Cottrell,Judith A. Burger,Patricia van der Woude,Leanne C. Helgers,Ilhan Tomris,Celia C. LaBranche,David C. Montefiori,Andrew B. Ward,Dennis R. Burton,John P. Moore,Rogier W. Sanders,Shane Crotty,George M. Shaw,Marit J. van Gils	2021	12
14	The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection PLoS Pathogens ·Tysheena P. Charles,Samantha L. Burton,Prabhu S. Arunachalam,Christopher A. Cottrell,Leigh M. Sewall,Venkata S. Bollimpelli,Sailaja Gangadhara,Antu Dey,Andrew B. Ward,George M. Shaw,Eric Hunter,Rama Rao Amara,Bali Pulendran,Marit J. van Gils,Cynthia A. Derdeyn	2021	17
15	Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variantsbreakdown → Science ·Meng Yuan,Deli Huang,Chang‐Chun D. Lee,Nicholas C. Wu,Abigail M. Jackson,Xueyong Zhu,Hejun Liu,Linghang Peng,Marit J. van Gils,Rogier W. Sanders,Dennis R. Burton,S. Momsen Reincke,Harald Prüß,Jakob Kreye,David Nemazee,Andrew B. Ward,Ian A. Wilson	2021	196
16	A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern npj Vaccines ·Mitch Brinkkemper,Philip J. M. Brouwer,Pauline Maisonnasse,Marloes Grobben,Tom G. Caniels,Meliawati Poniman,Judith A. Burger,Ilja Bontjer,Melissa Oomen,Joey H. Bouhuijs,Félix Armando Nuñez,Julien Villaudy,Yme U. van der Velden,Kwinten Sliepen,Marit J. van Gils,Roger Le Grand,Rogier W. Sanders	2021	8
17	Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets Blood ·Alexander P. Bye,Willianne Hoepel,Joanne Mitchell,Jasline Ng,Silvia Loureiro,Tanya Sage,Gestur Vidarsson,Jan Nouta,Manfred Wuhrer,Gerhard Ptz,Marit J. van Gils,Neline Kriek,Nichola Cooper,Ian M. Jones,Jeroen den Dunnen,Jonathan M. Gibbins	2021	67
18	An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain Cell Reports ·Nicholas C. Wu,Meng Yuan,Hejun Liu,Chang‐Chun D. Lee,Xueyong Zhu,Sandhya Bangaru,Jonathan L. Torres,Tom G. Caniels,Philip J. M. Brouwer,Marit J. van Gils,Rogier W. Sanders,Andrew B. Ward,Ian A. Wilson	2020	95
19	A Recombinant HIV Envelope Trimer Selects for Quaternary Dependent Antibodies Targeting the Trimer Apex AIDS Research and Human Retroviruses ·Devin Sok,Marit J. van Gils,Matthias Pauthner,Karen L. Saye-Francisco,Jessica Hsueh,Bryan Briney,Jean‐Philippe Julien,Peter S. Lee,Yuanzi Hua,John P. Moore,Ian A. Wilson,Rogier W. Sanders,Dennis R. Burton	2014	3
20	Evolution of Human Immunodeficiency Virus Type 1 in a Patient with Cross-Reactive Neutralizing Activity in Serum Journal of Virology ·Marit J. van Gils,Diana Edo-Matas,Emma J. Bowles,Judith A. Burger,Guillaume B. E. Stewart-Jones,Hanneke Schuitemaker	2011	7

About Marit J. van Gils

Marit J. van Gils is a scholar working on Virology, Infectious Diseases and Immunology, having authored 123 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (57 papers), SARS-CoV-2 and COVID-19 Research (36 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), Immune Cell Function and Interaction (21 papers), HIV/AIDS drug development and treatment (19 papers), COVID-19 Clinical Research Studies (18 papers), COVID-19 Impact on Reproduction (14 papers) and T-cell and B-cell Immunology (12 papers). The work is most often cited by research in Virology (2.2k citations), Infectious Diseases (1.5k citations) and Immunology (1.4k citations). Marit J. van Gils has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson, John P. Moore, Hanneke Schuitemaker, Dennis R. Burton, Jean‐Philippe Julien, Albert Cupo, Terri Wrin and Zelda Euler. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Frontiers in Immunology, iScience and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact